XBiotech Inc. Common Stock (NASDAQ: XBIT) last traded at $2.16, down 4.85% on the session. The quote above updates while this page is open; the figures below are drawn from XBiotech Inc. Common Stock’s own filings and are restated only when a new one is published.
XBiotech Inc. Common Stock trades on NASDAQ under the ticker XBIT. Its market capitalisation is $65.85 million.
Valuation measures for XBiotech Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $65.85M |
|---|---|
| Enterprise value | -$38.48M |
| Price / book | 0.51 |
| Beta | 0.50 |
Trailing-twelve-month figures tagged in XBiotech Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$45.13M |
| EPS (TTM) | -$1.47 |
|---|
| Return on equity | -35.13% |
|---|
| Cash | $109.53M |
|---|
Range and volume for XBIT over the past 52 weeks.
| 52-week high | $3.44 |
|---|---|
| 52-week low | $2.09 |
| Volume | 78.4K |
| Average volume | 40.8K |
| Previous close | $2.27 |
Invest a chosen dollar amount in XBiotech Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell XBIT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.